Research studies including randomized controlled trials often have a time-to-event outcome as the primary outcome of interest, although competing events can precede the event of interest and thus may prevent the primary outcome from occurring - for example mortality may prevent observing cancer recurrence or may preclude need for reoperation in patients who undergo surgical repair of heart valves. Researchers often use Kaplan-Meier survival curves or the Cox proportional hazards regression model to estimate survival in the presence of censoring. These models can provide biased estimates (usually upward) of the incidence of the primary outcome over time and therefore other models which address competing risks, such as the Fine-Gray subdistribution hazards model, may be more suitable for estimating the absolute incidence of the primary outcome as well as the relative effect of treatment on the cumulative incidence function (CIF). My question is whether the Nelson-Aalen estimator is a reasonable option for estimating the hazard function and the cumulative incidence of the outcome of interest in the scenario of competing risks and if so, why is this a preferred approach over the Kaplan-Meier estimator?

More David Zurakowski's questions See All
Similar questions and discussions